STAPLETON CRAIG R

Insider Buys Quantity –
18
2017-12-15PurchaseAvadel Pharmaceuticals plc
AVDL
director
280,000
0.7108%
$8.67$2.43M-22.41%
2017-11-27SaleAvadel Pharmaceuticals plc
AVDL
director
508,530
1.287%
$9.35$4.76M-26.41%
2017-09-12PurchaseAvadel Pharmaceuticals plc
AVDL
director
40,000
0.1038%
$9.52$380,720-16.48%
2017-05-22PurchaseAvadel Pharmaceuticals plc
AVDL
director
33,800
0.0829%
$9.76$329,888-4.96%
2017-05-19PurchaseAvadel Pharmaceuticals plc
AVDL
director
6,200
0.0151%
$9.83$60,946-6.31%
2017-05-18PurchaseAvadel Pharmaceuticals plc
AVDL
director
22,026
0.0534%
$9.98$219,819-8.09%
2016-11-29PurchaseAvadel Pharmaceuticals plc
AVDL
director
20,000
0.0487%
$10.85$217,000-8.52%
2016-11-28PurchaseAvadel Pharmaceuticals plc
AVDL
director
20,000
0.0492%
$10.79$215,870-7.06%
2016-09-01PurchaseAbercrombie & Fitch Co.
ANF
director
10,000
0.015%
$17.65$176,500-26.4%
2016-09-01PurchaseAvadel Pharmaceuticals plc
AVDL
director
20,000
0.0473%
$13.52$270,380-26.42%
2016-08-26PurchaseAvadel Pharmaceuticals plc
AVDL
director
40,000
0.0969%
$13.76$550,281-25.49%
2016-05-16PurchaseAvadel Pharmaceuticals plc
AVDL
director
4,830
0.0116%
$9.25$44,678+12.57%
2016-05-13PurchaseAvadel Pharmaceuticals plc
AVDL
director
49,626
0.1189%
$9.21$457,105+12.45%
2016-03-14PurchaseAvadel Pharmaceuticals plc
AVDL
director
200,000
0.4922%
$10.39$2.08M+5.47%
2015-06-22PurchaseAbercrombie & Fitch Co.
ANF
director
10,000
0.0142%
$22.42$224,200+4.9%
2014-05-30PurchaseAbercrombie & Fitch Co.
ANF
director
10,000
0.0135%
$37.30$373,000-22.94%
2013-06-25PurchaseAbercrombie & Fitch Co.
ANF
director
10,000
0.013%
$44.02$440,150-14.47%
2012-05-22PurchaseAbercrombie & Fitch Co.
ANF
director
10,000
0.0121%
$35.43$354,295+24.65%
2011-09-20SaleAbercrombie & Fitch Co.
ANF
director
7,398
0.0087%
$69.70$515,641-30.65%
2010-08-20PurchaseAbercrombie & Fitch Co.
ANF
director
7,398
0.0082%
$35.51$262,703+56.32%